Fasenra (benralizumab; AstraZeneca/Kyowa Hakko Kirin) Drug Analysis 2018 - ResearchAndMarkets.com

DUBLIN--()--The "Drug Analysis: Fasenra" drug pipelines has been added to ResearchAndMarkets.com's offering.

Fasenra (benralizumab; AstraZeneca/Kyowa Hakko Kirin) is a humanized monoclonal antibody which binds to the alpha chain of the interleukin (IL)-5 receptor on eosinophils and therefore depletes them. Elevated eosinophils are related to the cause and severity of asthma, as well as to asthma exacerbations. This mechanism of action differs from Nucala (mepolizumab; GlaxoSmithKline) and Cinqair (reslizumab; Teva), which bind to the IL-5 ligand, and this is proposed to lead to a faster onset of action.

Key Topics Covered:

1 Product Profiles

  • Fasenra: Asthma
  • benralizumab: Chronic obstructive pulmonary disease (COPD)

List of Figures

Figure 1: Fasenra for asthma - SWOT analysis

Figure 2: The author's drug assessment summary of Fasenra in asthma

Figure 3: The author's drug assessment summary of Fasenra in asthma

Figure 4: Fasenra sales for asthma across the US, Japan, and five major EU markets, by country, 2017-26

List of Tables

Table 1: Fasenra drug profile

Table 2: Fasenra Phase III trials in asthma

Table 3: Ongoing Phase III trials for Fasenra in asthma

Table 4: Fasenra sales for asthma across the US, Japan, and five major EU markets, by country ($m), 2017-26

Table 5: Benralizumab drug profile

Table 6: Phase III clinical trials for benralizumab in COPD

Table 7: Phase IIa clinical trial data for benralizumab in COPD

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/dg77fk/fasenra?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Respiratory Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Respiratory Drugs